Novartis AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11,435	11,459	13,393	7,517	12,407
Short-Term Investments	155	1,892	680	11,209	15,817
Cash & Short-Term Investments	11,590	13,351	14,073	18,726	28,224
Cash Growth	-13.19%	-5.13%	-24.85%	-33.65%	147.49%
Accounts Receivable	8,937	7,423	7,107	8,066	8,005
Other Receivables	205	1,939	2,140	1,735	1,558
Receivables	9,142	9,362	9,247	9,801	9,563
Inventory	6,269	5,723	5,913	7,175	6,666
Prepaid Expenses	-	985	764	911	1,102
Other Current Assets	3,459	283	484	297	163
Total Current Assets	30,460	29,704	30,481	36,910	45,718
Property, Plant & Equipment	12,352	10,873	10,924	12,195	13,106
Long-Term Investments	2,446	1,128	1,827	1,606	2,268
Goodwill	25,567	24,756	23,341	29,301	29,595
Other Intangible Assets	29,411	26,915	26,879	27,223	28,683
Long-Term Accounts Receivable	-	54	104	59	70
Long-Term Deferred Tax Assets	5,438	4,359	4,309	3,739	3,743
Long-Term Deferred Charges	-	-	-	4,421	5,499
Other Long-Term Assets	5,275	4,355	1,966	1,914	3,035
Total Assets	110,949	102,246	99,945	117,453	131,795
Accounts Payable	4,456	4,572	4,926	5,146	5,553
Accrued Expenses	-	5,250	5,174	5,387	5,149
Short-Term Debt	-	4,733	3,893	3,635	3,606
Current Portion of Long-Term Debt	5,602	3,499	2,282	2,296	2,689
Current Portion of Leases	263	235	230	251	275
Current Income Taxes Payable	1,969	1,599	1,893	2,533	2,415
Current Unearned Revenue	-	127	98	123	123
Other Current Liabilities	14,988	8,677	7,894	9,285	10,398
Total Current Liabilities	27,278	28,692	26,390	28,656	30,208
Long-Term Debt	27,935	21,366	18,436	20,244	22,902
Long-Term Leases	1,657	1,568	1,598	1,538	1,621
Pension & Post-Retirement Benefits	-	2,473	2,730	2,639	3,789
Long-Term Deferred Tax Liabilities	3,397	2,419	2,248	2,686	3,070
Other Long-Term Liabilities	4,133	1,602	1,793	2,267	2,383
Total Liabilities	64,400	58,120	53,195	58,030	63,973
Common Stock	766	793	825	890	901
Retained Earnings	-	46,561	49,649	63,540	70,989
Treasury Stock	-50	-53	-41	-92	-48
Comprehensive Income & Other	45,414	-3,255	-3,766	-4,996	-4,187
Total Common Equity	46,130	44,046	46,667	59,342	67,655
Minority Interest	419	80	83	81	167
Shareholders' Equity	46,549	44,126	46,750	59,423	67,822
Total Liabilities & Equity	110,949	102,246	99,945	117,453	131,795
Total Debt	35,457	31,401	26,439	27,964	31,093
Net Cash (Debt)	-23,867	-18,050	-12,366	-9,238	-2,869
Net Cash Per Share	-12.20	-8.87	-5.91	-4.20	-1.27
Filing Date Shares Outstanding	1,913	1,975	2,044	2,120	2,235
Total Common Shares Outstanding	1,913	1,975	2,044	2,120	2,235
Working Capital	3,182	1,012	4,091	8,254	15,510
Book Value Per Share	24.11	22.30	22.83	28.00	30.27
Tangible Book Value	-8,848	-7,625	-3,553	2,818	9,377
Tangible Book Value Per Share	-4.63	-3.86	-1.74	1.33	4.20
Land	-	376	403	451	492
Buildings	-	9,526	10,147	11,396	11,819
Machinery	-	9,046	9,630	11,842	13,328
Construction In Progress	-	1,610	1,213	1,184	1,508

Source: S&P Global Market Intelligence. Standard template. Financial Sources.